AZN: ASTRAZENECA PLC Profile

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 29 hrs, 52 mins

Symbol	Value	Change	Percentage Change
DJIA	11,288.54	73.03	0.65%
NASDAQ	2,245.38	-6.08	-0.27%
S&P 500	1,262.90	1.38	0.11%

ASTRAZENECA PLC

AZN

Stock price

45.80 1.67 3.78%

as of 01:00 PM EDT on 07/03/2008 in USD (NYSE Delay: 20 mins.)
Extended Hours

— — —

Analyst Consensus

Hold
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: AZN

ASTRAZENECA PLC Profile

AstraZeneca's products run the gamut from A (breast cancer drug Arimidex) to Z (migraine treatment Zomig). One of the world's top pharmaceutical firms, AstraZeneca specializes in drugs for gastrointestinal, cardiovascular, neurology, and oncology therapeutic areas. The firm's biggest seller is acid reflux remedy Nexium. For matters of the heart, AstraZeneca makes hypertension and heart failure drug Atacand and cholesterol reducer Crestor. The company's other drugs include Seroquel (schizophrenia) and Zoladex (prostate cancer). AstraZeneca, like many in its class, suffers a bit from a lack of real pipeline growth; to that end, the company in 2007 purchased MedImmune to bolster its biologics business.

David Brennan: CEO

15 Stanhope Gate

London W1K 1LN, United Kingdom

http://www.astrazeneca.com

Phone: +44-20-7304-5000

Fax: +44-20-7304-5151

Sector: Healthcare Industry: Drugs

2007 Sales	2007 Sales Growth	2007 Net Income	2006 Employees
$29,559,000,000	11.6%	$5,627,000,000	66,000

Key Executives: AZN

Name	Title	Officer Since
David Brennan	CEO	3/14/05
SIMON LOWTH	CFO	11/5/07
John Varley	Director	7/26/06
Marcus Wallenberg	Director	4/6/99
John Buchanan	Director	4/25/02
Michele Hooper	Director	7/1/03
Professor Dame Nancy Rothwell	Director	4/27/06
David Smith	Executive VP, Divisional	-

View All Key Executives

John Varley, Appointed as a Director 26 July 2006. Executive Director of Barclays Bank plc and Barclays plc since 1998 and Group Chief Executive since 2004. President of the Employers' Forum on Disability and member of the International Advisory Panel of the Monetary Authority of Singapore. Treasurer and Trustee of St. Dunstan's, Trustee of Thornton Smith Plevins Young People's Trust and Chairman of Business Action on Homelessness.... View Full Profile

John Varley

Marcus Wallenberg, Appointed as a Director 6 April 1999. Formerly a Director of Astra AB (appointed 18 May 1989). Chairman of Skandinaviska Enskilda Banken AB. Chairman of Saab AB. Vice-Chairman of Telefonaktiebolaget LM Ericsson. Chairman of the Board of Electrolux AB. Non-Executive Director of Stora Enso Oyj and the Knut and Alice Wallenberg Foundation. Chairman of International Chamber of Commerce (ICC).... View Full Profile

Marcus Wallenberg

John Buchanan, Appointed as a Director 25 April 2002. Executive Director and Group Chief Financial Officer of BP p.l.c. 1996-2002. Member of the UK Accounting Standards Board 1997-2001. Senior Independent Director of BHP Billiton Plc. Deputy Chairman of Vodafone Group Plc. Chairman of Smith & Nephew plc.... View Full Profile

John Buchanan

Michele Hooper, Appointed as a Director 1 July 2003. President and Chief Executive Officer of Stadtlander Drug Company 1998-1999. Corporate Vice-President and President, International Businesses of Caremark International Inc. 1992-1998. Public Corporate Director of UnitedHealth Group. Non-Executive Director of PPG Industries, Inc.. Non-Executive Director of Warner Music Group, Inc.... View Full Profile

Michele Hooper

Professor Dame Nancy Rothwell, Appointed as a Director 27 April 2006. Also has responsibility for overseeing Corporate Responsibility. MRC Research Professor and Deputy President and Deputy Vice Chancellor at the University of Manchester. Trustee of Cancer Research UK and the Campaign for Medical Progress, Chair of the Research Defence Society, Chair of the Wellcome Trust Public Engagement Strategy Panel. Council member of the Biotechnology and... View Full Profile

Professor Dame Nancy Rothwell

Professor Dame Nancy Rothwell, Appointed as a Director 27 April 2006. Also has responsibility for overseeing Corporate Responsibility. MRC Research Professor and Deputy President and Deputy Vice Chancellor at the University of Manchester. Trustee of Cancer Research UK and the Campaign for Medical Progress, Chair of the Research Defence Society, Chair of the Wellcome Trust Public Engagement Strategy Panel. Council member of the Biotechnology and... View Full Profile

David Smith

Professor Dame Nancy Rothwell, Appointed as a Director 27 April 2006. Also has responsibility for overseeing Corporate Responsibility. MRC Research Professor and Deputy President and Deputy Vice Chancellor at the University of Manchester. Trustee of Cancer Research UK and the Campaign for Medical Progress, Chair of the Research Defence Society, Chair of the Wellcome Trust Public Engagement Strategy Panel. Council member of the Biotechnology and... View Full Profile

Jan Lundberg

Professor Dame Nancy Rothwell, Appointed as a Director 27 April 2006. Also has responsibility for overseeing Corporate Responsibility. MRC Research Professor and Deputy President and Deputy Vice Chancellor at the University of Manchester. Trustee of Cancer Research UK and the Campaign for Medical Progress, Chair of the Research Defence Society, Chair of the Wellcome Trust Public Engagement Strategy Panel. Council member of the Biotechnology and... View Full Profile

Bruno Angelici

Professor Dame Nancy Rothwell, Appointed as a Director 27 April 2006. Also has responsibility for overseeing Corporate Responsibility. MRC Research Professor and Deputy President and Deputy Vice Chancellor at the University of Manchester. Trustee of Cancer Research UK and the Campaign for Medical Progress, Chair of the Research Defence Society, Chair of the Wellcome Trust Public Engagement Strategy Panel. Council member of the Biotechnology and... View Full Profile

Tony Zook

Louis Schweitzer, Appointed as a Director 11 March 2004. Non-Executive Chairman of Renault SA since April 2005. Chairman and Chief Executive Officer of Renault SA 1992-2005. President of the Management Board of Renault-Nissan BV 2002-2005. Chief Financial Officer and Executive Vice-President 1988-1990 and President and Chief Operating Officer 1990- 1992, Renault SA. Non-Executive Director of BNP-Paribas, Electricite de France, Veolia... View Full Profile

Louis Schweitzer

Appointed as a Director 1 January 1997. Also has responsibility for overseeing Corporate Responsibility. Chairman of the Medicines for Malaria Venture and the Association of Medical Research Charities. Trustee of Cancer Research UK. Chairman of the Trustees of the AstraZeneca Science Teaching Trust.... View Full Profile

Dame Bridget Ogilvie

David R. Brennan, Appointed as a Director 14 March 2005. Appointed Chief Executive Officer 1 January 2006. Member of the Executive Board of the Pharmaceutical Research and Manufacturers of America (PhRMA). Honorary Board member of the US CEO Roundtable on Cancer, Board member of the European Federation for Pharmaceutical Industries and Associations (EFPIA). Executive Vice-President, North America, AstraZeneca PLC 2001-2005. Chairman of the Board... View Full Profile

David Brennan

Graeme Musker, Appointed as Company Secretary 6 June 1993.... View Full Profile

Graeme Musker

Hakan Mogren, KBE, Appointed as a Director 6 April 1999. Formerly Chief Executive Officer and a Director of Astra AB (appointed 18 May 1988). Member of the Board of Directors of Investor AB and Groupe Danone. Director of the Marianne and Marcus Wallenberg Foundation. Member of the Royal Swedish Academy of Engineering Sciences.... View Full Profile

Hakan Mogren, KBE

Jane Henney, Appointed as a Director 24 September 2001. Currently Professor of Medicine, University of Cincinnati. Prior appointments include: Senior Vice-President and Provost for Health Affairs, University of Cincinnati Medical Academic Health Center; Deputy Director, US National Cancer Institute; Deputy Commissioner for Operations, US Food and Drug Administration; and Commissioner of Food and Drugs, US Food and Drug Administration.... View Full Profile

Jane Henney

John Patterson, CBE, FRCP, Appointed as a Director 1 January 2005. Fellow of the Royal College of Physicians. Director of the British Pharma Group. Non-Executive Director of Cobham plc. Non-Executive Director of Amersham plc 2001-2004. President of the Association of the British Pharmaceutical Industry 2002-2004. Member of the Supervisory Board of the UK Medicines Control Agency 1990-1994. Executive Vice-President, Product Strategy & Licensing... View Full Profile

John Patterson, FRCP

John Patterson, CBE, FRCP, Appointed as a Director 1 January 2005. Fellow of the Royal College of Physicians. Director of the British Pharma Group. Non-Executive Director of Cobham plc. Non-Executive Director of Amersham plc 2001-2004. President of the Association of the British Pharmaceutical Industry 2002-2004. Member of the Supervisory Board of the UK Medicines Control Agency 1990-1994. Executive Vice-President, Product Strategy & Licensing... View Full Profile

David Mott

Simon Lowth, Appointed as a Director 5 November 2007. Also has overall responsibility for Information Services. Finance Director, Scottish Power plc 2005-2007 and Executive Director, Corporate Strategy and Development, Scottish Power plc 2003-2005. Director - Head of UK Industrial Practice, McKinsey & Company 2000-2003.... View Full Profile

SIMON LOWTH

Bo Angelin, Appointed as a Director 24 July 2007. Professor of Clinical Metabolism at Karolinska Institutet and Head of the Department of Endocrinology, Metabolism and Diabetes at the Karolinska University Hospital in Stockholm, Sweden. Member of the Board of Karolinska Institute. Member of the Nobel Assembly and of the Swedish Royal Academy of Sciences. Member of the Medical Nobel Institute. Prior appointments include Chairman of the Nobel... View Full Profile

Bo Angelin

Bo Angelin, Appointed as a Director 24 July 2007. Professor of Clinical Metabolism at Karolinska Institutet and Head of the Department of Endocrinology, Metabolism and Diabetes at the Karolinska University Hospital in Stockholm, Sweden. Member of the Board of Karolinska Institute. Member of the Nobel Assembly and of the Swedish Royal Academy of Sciences. Member of the Medical Nobel Institute. Prior appointments include Chairman of the Nobel... View Full Profile

Lynn Tetrault

Top Competitors: AZN

View Detailed Competitors Chart

Insider Trends: AZN
Sentiment for AZN is —
- 0M
- 2M
- 4M
- 6M
- Market Value of Insider Sales
- Market Value of Insider Purchases
Total dollar value of all insider purchases and sales over 12 months
View All Insider Sentiment

Insider Transactions: AZN

Date	Name	Shares	Transaction Type	Market Value

View All Insider Activity

Ownership Breakdown : AZN

Large Block Holder Type	Number
Institutions	284.00
Mutual Fund	187.00
Other Major	2.00

Full Details

Indices : AZN

Symbol	Name	Last Trade	Change

View all Indices that include AZN

Short Interest Volume: AZN

Data as of —

Current Short Interest Shares	1.10 B
Current Short Interest Ratio	5.30
Float	—

Short Interest as % of Float	—
Average Daily Volume	1.18 M
Outstanding Shares	1.45 B

Full Details

SEC Filings: AZN

Accepted Date	Description
06/19/2008	SEC Filing: Foreign Issuer Report
05/07/2008	SEC Filing: Foreign Issuer Report
04/03/2008	SEC Filing: Foreign Issuer Report

View all SEC Filings

Get Quote Details for:

- Help & Feedback

Market Movers

Related Resources

My Portfolios

AOL Real-Time Streaming Quotes

ASTRAZENECA PLC

AZN

Stock price

45.80 1.67 3.78%

as of 01:00 PM EDT on 07/03/2008 in USD (NYSE Delay: 20 mins.)
Analyst Consensus
- Strong Buy
- Buy
- Hold
- Sell
- Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: AZN

Quote Search Search the Web Search

More in Money & Finance
- Money
- Earnings
- Tech News
- Stock Screener
- Banking
- Checking Account
- Savings Account
- Credit Cards
- Credit Reports
- Identity Theft
- Debt Management
- Loans
- Auto Loan
- Personal Loans
- Mortgages
- Refinancing
- Taxes
- Online Tax Filing
- Tax Advice
- Tax Basics
- Tax Forms
- Audit
- Tax Credit
- Tax Deduction
- AMT
- Small Business
- BloggingStocks
- BloggingBuyouts
- Luxist
- TUAW
- DJIA
- Dow Jones Industrial Average
More Stock Research
Notices and Terms: Confirm all data with your broker before trading.

Quote data provided by Interactive Data. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Financial.

© 2008 AOL LLC. All Rights Reserved.

AOL@Money © 2008 AOL LLC. All Rights Reserved.

Live Updates:

Ticker

Dynamic view of the market

ASTRAZENECA PLC

AZN

Stock price

Extended Hours

Analyst Consensus

ASTRAZENECA PLC Profile

Key Executives: AZN

Top Competitors: AZN

Insider Trends: AZN

Insider Transactions: AZN

Ownership Breakdown : AZN

Indices : AZN

Short Interest Volume: AZN

SEC Filings: AZN

Quote Details

Classic Chart

Advanced Chart BETA

Real-Time Headlines

Message Boards

Profile

Earnings Analysis

Event Calendar

Financials